The Global Connections Fund is an initiative of the Australian Government’s National Innovation and Science Agenda (NISA) funded by the Department of Industry, Innovation and Science. You can see Bridging Grant Awardees here
A Victorian emergency medicine company has risen to become a global leader, thanks to its range of respiratory medications. Offering new devices for asthma and chronic obstructive pulmonary disease (COPD), Medical Developments International (MDI), is turning its attention…
LBT Innovations Ltd (LBT) has been awarded the 2017 SA Science Excellence Award for “Excellence in Research Collaboration”. The award recognises excellence in developing a world leading intelligent medical device in South Australia, and the collaboration between the…
VivaGel® BV consistently resulted in reduced rates of BV recurrence by the primary efficacy endpoint and five secondary efficacy measures, and delayed time to first recurrence VivaGel® BV resulted in sustained benefits 3 months after cessation of treatment…
Australian medical technology company LBT Innovations Limited (ASX:LBT) has entered a collaboration agreement with Central Adelaide Local Health Network (CALHN) Vascular and Endovascular Services, to use LBT’s novel WoundVue™ prototype device in the clinical trial, “Predicting outcomes in…
Clinical trials are an integral part of the research and development of new treatments, interventions or tests, and the refinement of existing standards of care and clinical practices. As such, they are vital to the future of healthcare.…
People with profound vision loss are one step closer to having their sight effectively restored, thanks to a new investment from Australia’s chief science body into a large-scale scientific computing system. The new Bracewell system, which is being used by Data61’s computer vision group that…
Therapeutic goods regulation and legislation can be challenging to navigate. The SME Assist hub is designed to help small and medium enterprises, and R&D groups developing new medicines and medical devices (including apps) understand their regulatory and legislative…
Victorian Clinical Trials – Gateway is a new digital portal for accessing clinical trial partners in Victoria. St Vincents Hospital Melbourne and the Victorian Government’s Department of Economic Development, Jobs, Training and Resources (DEDJTR) are collaborating to create the Gateway…
Victoria has one of the world’s largest life science clusters composed of the medical technology (medtech), biotechnology (biotech) and pharmaceutical industries. It is home to a vibrant commercial sector, key R&D infrastructure and advanced manufacturing expertise making it…
July 2017 Restoration on skilled visas welcomed across medical technology, biotechnology and pharmaceutical sector. The restoration of key occupations for the medical technology, research and pharmaceutical sector to the skilled migration visa list has been welcomed by six…
July 2017 Revisions to the skilled migration list have been welcomed by many BioMelbourne Network members across the biotechnology, medical technology and pharmaceutical sector. The restoration of occupations such as life scientist, biotechnologist, CEO/General Manager, and biochemist to…